We’re putting the EMPHASIS back on CELIAC DISEASE .

How can you take care of your body, mind, and soul all at once? Sign up for our September Step Beyond Celiac 5K of course!

New bill would require all gluten containing grains be disclosed on food packaging ingredient labels

Beyond Celiac Chief Scientist and Strategy Officer, Salvatore Alesci, MD, PhD answers frequently asked questions about celiac disease and COVID-19 vaccines.

The Beyond Celiac Established Investigator Grant award will expand understanding of the effects of gluten on the brains of people with celiac disease

In this article Beyond Celiac CEO Alice Bast shares her top tips for traveling safely with celiac disease. She believes it’s important to continue living as “normal” a life as possible after a celiac disease diagnosis. That includes travel.

Children who had no symptoms but were diagnosed with celiac disease as part of a mass pediatric screening program reported a better quality of life overall after a year on the gluten-free diet, preliminary results of a study funded by Beyond Celiac show.

An international group of researchers are investigating a monoclonal antibody that has the potential to treat celiac disease by stopping the activation of cells that identify gluten as an invader.

Italian researchers hypothesize that COVID-19 could have implications for those who are genetically at risk for celiac disease

The mouth and the intestine share characteristics that might make a saliva test for celiac disease the first step in diagnosis, a new study from Spain suggests.

Two European studies paint a discouraging picture of how well celiac disease is understood in the medical community. Some of what they conclude is likely to be applicable to the United States, too.

Foods for when you suffer from both celiac disease and diverticulitis

Monitoring celiac disease

How to tell if ongoing symptoms are from celiac disease

What’s the point of follow-up testing and monitoring?

Are gluten-free and wheat-free the same?

PRV-015 has previously been studied for its potential to reduce symptoms and inflammation triggered by gluten in people with celiac disease.

Latiglutenase development continues with initial CeliacShield™ study results and ongoing Solutions for Celiac™ clinical study actively recruiting participants

Celiac disease community is an integral part of research into this potential immune tolerance treatment

Recruitment of symptomatic participants in the first celiac disease Phase 3 clinical trial continues

New potential treatment for celiac disease aims to re-educate the immune system so it does not react to gluten